This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kobayashi, S. Articles by Tsunematsu, T. Search for Related Content PubMed PubMed Citation Articles by Kobayashi, S. Articles by Tsunematsu, T. Social Bookmarking                         What's this?

Effect of Long-Term Administration of Buflomedil on Regional Cerebral Blood Flow in Chronic Cerebral Infarction

Third Division of Internal Medicine, Shimane Medical University, Shimane, Japan

Shuhei Yamaguchi

Third Division of Internal Medicine, Shimane Medical University, Shimane, Japan

Kazunori Okada

Third Division of Internal Medicine, Shimane Medical University, Shimane, Japan

Mitsuhiro Kitani

Third Division of Internal Medicine, Shimane Medical University, Shimane, Japan

Kazuya Yamashita

Third Division of Internal Medicine, Shimane Medical University, Shimane, Japan

Kouichi Shimote

Third Division of Internal Medicine, Shimane Medical University, Shimane, Japan

Tokugoro Tsunematsu

Third Division of Internal Medicine, Shimane Medical University, Shimane, Japan

The influence of long-term oral administration of buflomedil on regional cerebral blood flow was investigated in 10 patients with chronic cerebral infarc tion and mild to moderate mental deterioration. Patients were given 150 mg buflomedil three times daily for a period of eight weeks. Regional cerebral blood flow (rCBF) was measured in patients before they began buflomedil treat ment and during the last week of treatment. The interval of the rCBF measure ments in the control subjects (n=12) ranged from seven to forty-eight days. Mental function in the patients studied was evaluated by use of Hasegawa's simple intelligence scale for the aged and Zung's self-rating depression scale, before and during the last week of buflomedil treatment. The results showed a mean increase in rCBF of 10.5%±12.1% in the patient group. The control group demonstrated virtually no change in rCBF measurements. Improvements in the mental function scores of the buflomedil-treated group were noted, and 5 of the 10 patients reported improvement in subjective symptoms.

Angiology, Vol. 39, No. 11, 934-941 (1988)
DOI: 10.1177/000331978803901102


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?